Group 1: Peanut allergic individuals (n: 20) Group 2: Allergic/atopic individuals (not allergic to peanut); (n:20) Group 3: Non allergic individuals (healthy controls;n:20) Group 4: Allergic individuals receiving xolair therapy (n: 20)